On November 17, 2023, Chris Schelling, Acer's Chief Executive Officer ceased to be an executive officer of Acer Therapeutics Inc.
Acer Therapeutics Inc.
Equities
ACER
US00444P1084
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+16.13% | 12TCr | |
+19.65% | 12TCr | |
+21.22% | 2.66TCr | |
-23.84% | 1.99TCr | |
-17.47% | 1.63TCr | |
-45.95% | 1.55TCr | |
-19.28% | 1.55TCr | |
+63.81% | 1.48TCr | |
+1.94% | 1.37TCr |